Richmond, Jan. 30, 2024 (GLOBE NEWSWIRE) -- According to a research report "Leadless pacemakers market”, By Product Type (Micra Transcatheter Pacing System (TPS), Nanostim Leadless Pacemaker, Wireless Cardiac Simulation System (WCSS), Dual-chamber Leadless Pacemakers (DLP), Others), Applications (Bradycardia, Atrioventricular (AV) block, Sick sinus syndrome, Others), End- Users (Hospitals, Cardiac Clinics, Ambulatory Surgical Centers) and Region - Global Forecast to 2030.
Global Leadless Pacemakers Market Report Scope:
| Report | Details |
| Market size value in 2023 | USD 600.31 Million |
| Market size value in 2030 | USD 1,676.23 Million |
| CAGR (2023-2030) | 15.8% |
| Forecast Period | 2023–2030 |
| Historic Data | 2019 |
| Forecast Units | Value (USD Million/USD Billion) |
| Segments Covered | Product Type, Applications, End User and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and RoW |
| |
| |
| Sample of Companies Covered |
|
| |
|
Download the Sample - https://www.marketdigits.com/request/sample/3891
TOC Covers in Depth & Breath on Leadless Pacemakers Market
170 - Market Data Tables
65 - List of Figures
225 – Pages
The report includes Vendor Assessment (Company Profiles, Market Positioning, Strategies, Recent Developments, Capabilities & Product Offerings / Mapping), Technology Assessment (Developments & Economic Impact), Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional FootPrint by MarketDigits.
Market Overview
The leadless pacemakers market is witnessing significant growth driven by technological advancements, rising prevalence of cardiac disorders, and increasing demand for minimally invasive procedures. Leadless pacemakers offer several advantages over traditional devices, including reduced risk of infection, elimination of leads-related complications, and smaller device size. Moreover, the expanding geriatric population, coupled with the growing adoption of sedentary lifestyles, is further fueling the demand for leadless pacemakers. Additionally, favorable reimbursement policies and increasing healthcare expenditure are expected to bolster market expansion. However, challenges such as high initial costs and limited availability of skilled professionals may impede market growth to some extent. Overall, with ongoing research and development efforts aimed at enhancing device performance and addressing existing limitations, the leadless pacemakers market is poised for continued advancement in the foreseeable future.
Major Vendors in the Global Leadless Pacemakers Market:
- Medtronic PLC
- Abbott Laboratories
- Boston Scientific Corporation
- Biotronik SE & Co. KG
- Lepu Medical Technology Co., Ltd
- Integer Holdings Corporation
- MicroPort Scientific Corporation
- Osypka AG
- Terumo Corporation
- EBR Systems, Inc.
Request for Discount @ https://www.marketdigits.com/request/discount/3891
Growing Geriatric Population
The growing geriatric population serves as a significant driver for the leadless pacemakers market due to the increased prevalence of cardiac conditions among older individuals. As people age, the risk of developing cardiovascular disorders, including arrhythmias and bradycardia, rises substantially. Leadless pacemakers offer a promising solution for this demographic as they provide a safer and more effective alternative to traditional pacemakers, particularly for elderly patients who may be more susceptible to complications associated with transvenous leads. Moreover, the aging population often prefers minimally invasive treatments that minimize discomfort and recovery time, making leadless pacemakers an attractive option. With the geriatric cohort representing a substantial portion of the global population and continuing to grow, the demand for leadless pacemakers is expected to escalate, driving further innovation and adoption in the cardiac rhythm management market.
Market Dynamics
Drivers:
- Increasing Incidence Of Bradyarrhythmia
- Growing demand for minimally invasive procedures
Opportunities:
- Increased Investments In Healthcare Infrastructure
- Increasing awareness among both patients and physicians
Increasing Preference for Minimally Invasive Cardiac Interventions
An increasingly notable trend in the leadless pacemakers market is the growing preference for minimally invasive cardiac interventions. This shift reflects a broader movement within healthcare towards procedures that offer reduced invasiveness, shorter recovery times, and fewer complications. Leadless pacemakers align with these preferences by eliminating the need for transvenous leads, which are associated with complications such as infections and lead fractures. As a result, patients and healthcare providers are increasingly opting for leadless pacemakers, recognizing their potential to improve patient outcomes and quality of life. This trend is further propelled by advancements in technology, which have led to the development of more sophisticated leadless pacing systems with enhanced features and compatibility, thereby driving market growth and innovation in the field of cardiac rhythm management.
North America dominates the market for Leadless pacemakers market.
North America's dominance in the leadless pacemakers market can be attributed to several key factors. Firstly, the region boasts advanced healthcare infrastructure and a high level of awareness among both healthcare professionals and patients regarding innovative medical technologies. This facilitates the adoption of leadless pacemakers, which are considered cutting-edge solutions for cardiac rhythm management. Additionally, favorable reimbursement policies in North America incentivize the utilization of leadless pacemakers, making them more accessible to patients. Moreover, the region's aging population, coupled with a high prevalence of cardiac disorders, drives the demand for advanced cardiac interventions, further propelling the growth of the leadless pacemakers market. Lastly, the presence of leading market players and ongoing research and development initiatives focused on enhancing the performance and capabilities of leadless pacemakers contribute to North America's dominant position in this market segment.
According to the American Heart Association, Inc., coronary heart disease (CHD) has emerged as the leading cause of cardiovascular disease (CVD)-related deaths in the United States, accounting for 41.2% of these fatalities. This underscores the urgent need for advanced technologies such as leadless pacemakers to address heart rhythm irregularities associated with CHD and improve overall cardiovascular health outcomes.
Micra Transcatheter Pacing System (TPS) Segments is anticipated to hold the Largest Market Share during the Forecast Period
Based on the Organization Size segment categorized into Micra Transcatheter Pacing System (TPS), Nanostim Leadless Pacemaker, Wireless Cardiac Simulation System (WCSS), Dual-chamber Leadless Pacemakers (DLP) and others. Micra Transcatheter Pacing System (TPS) has a major share in the Leadless pacemakers market. The Micra Transcatheter Pacing System (TPS) holds the major share in the leadless pacemakers market. This can be attributed to several factors. Firstly, Micra TPS has established itself as a pioneering and widely adopted leadless pacing system, offering numerous advantages such as minimally invasive implantation, reduced risk of complications associated with transvenous leads, and long battery life. Additionally, Micra TPS has received significant clinical validation and regulatory approvals, further enhancing its credibility and market acceptance. Its compact size and compatibility with MRI scans also contribute to its popularity among both patients and healthcare providers. Moreover, advancements in Micra TPS technology, such as enhanced programming capabilities and improved sensing algorithms, continue to drive its adoption, solidifying its position as the leading product in the leadless pacemakers market.
Inquire Before Buying: https://www.marketdigits.com/request/enquiry-before-buying/3891
Browse Similar Reports:
Cardiac Marker Testing Market 2030 By Type, Distribution Channel, End-user and Region - Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprints by MarketDigits
Cardiac Biomarker Diagnostic Test Kits Market 2030 By Type, Distribution Channel, End-user and Region - Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprints by MarketDigits
Cardiac Surgery Instruments Market 2030 By Type, Distribution Channel, End-user and Region - Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprints by MarketDigits
About MarketDigits:
MarketDigits is one of the leading business research and consulting companies that helps clients to tap new and emerging opportunities and revenue areas, thereby assisting them in operational and strategic decision-making. We at MarketDigits believe that a market is a small place and an interface between the supplier and the consumer, thus our focus remains mainly on business research that includes the entire value chain and not only the markets.
We offer services that are most relevant and beneficial to the users, which help businesses to sustain themselves in this competitive market. Our detailed and in-depth analysis of the markets catering to strategic, tactical, and operational data analysis & reporting needs of various industries utilize advanced technology so that our clients get better insights into the markets and identify lucrative opportunities and areas of incremental revenues.
Contact Us:
MarketDigits
1248 CarMia Way Richmond,
VA 23235,
United States.
USA: +1 847 450 0808
Email: sales@marketdigits.com
Web: https://www.marketdigits.com
Follow Us on: | Twitter | LinkedIn |
